Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?
Francesco Passiglia,
Silvia Novello
Affiliations
Francesco Passiglia
Corresponding author. Department of Oncology, University of Turin, San Luigi Hospital, Orbassano (TO), Italy.; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy
Silvia Novello
Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy
